Commonly asked questions for lung cancer screening

Introduction. Lung cancer screening (LCS) can reduce lung cancer mortality; however, poor understanding of results may impact patient experience and follow-up. We sought to determine whether an informational handout accompanying LCS results can improve patient-reported outcomes and adherence to follow-up.
Study Design. This was a prospective alternating intervention pilot trial of a handout to accompany LCS results delivery.
Setting/Participants. Patients undergoing LCS in a multisite program over a 6-month period received a mailing containing either: 1) a standardized form letter of LCS results (control) or 2) the LCS results letter and the handout (intervention).
Intervention. A two-sided informational handout on commonly asked questions after LCS was created through iterative mixed-methods evaluation with both LCS patients and providers.
Outcome Measures. The primary outcomes of 1)patient understanding of LCS results, 2)correct identification of next steps in screening, and 3)patient..., Study Population
This study was performed in a Seattle, Washington-based multisite program which oversees LCS provided by 4 tertiary care centers, 27 primary care clinics, specialty services, and self-referred patients. Screening is largely decentralized and managed by primary care providers. Central oversite is used to assist with scheduling and to standardize and track reporting. Screening results are sent to patients via standardized letter by the LCS program within 1 week of screening, with separate letter templates for each Lung-RADS category with additional information for those with “Other significant” or “S-findings.” Other results communication is at the discretion of the ordering physician and may include phone calls, visits, or communication through the electronic health record (EHR). Patients may also access their own LDCT reports through an EHR portal.
Study Design
This was a prospective, alternating-intervention controlled trial of the CAQ handout to accompany screening re..., , ## Commonly Asked Questions (CAQ) in Lung Cancer Screening Study

This is a study of 410 participants who underwent screening in 2020-2021 as a part of a trial in which participants were randomized to either: receive a CAQ with their results or receive usual care. Data presented includes participant characteristics, survey responses from respondents and follow-up lung cancer screening outcomes.

## Description of the data and file structure

The data are presented with full description of the data columns as the label. The file is a CSV file. Each row is a unique participant and each column represents a variable

Variable description:

Each participant is labeled with a unique four digit study ID starting with LCS. Eligibility for inclusion in the study is defined as 1/0.

The treatment arm (itt_group) is either the intervention (CAQ) or the control. The study_responder column describes whether they were enrolled in the study or whether they declined to participate (a non-respondent). T...